Visit us at PrecisionMed Exhibition and Summit 2023
We will be attending the PrecisionMed Exhibition and Summit 2023 at Dubai World Trade Center from May 23-24.
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the AmoyDx® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”) as a companion diagnostic for RET fusion-positive non-small cell lung cancer (“NSCLC”), for selpercatinib capsules 40 mg
AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
Say hello to us at booth 1220 and learn more about our companion diagnostic solutions.
Career Opportunities - The Field Application Scientist
The Field Application Scientist is responsible for system usage training at customer sites while providing PCR/NGS experimental design, data analysis, logistical, and troubleshooting support for LATAM.
Career Opportunities - Business Manager (EMEA)
You are looking for opportunities to bring to use your knowledge of and experience in oncology molecular diagnostics in qPCR and Next Generation Sequencing application? You are passionate in building meaningful relationship with both internal and external
AmoyDx to Exhibit at ESMO Asia Congress 2022
Amoy Diagnostics will be in the ESMO Asia Congress 2022, held in person in Singapore from December 2-4.